RxDoctor Payments Data

Tracy Meadows, APRN

Family · Somerset, KYNPI 1447523501

Payments from drug & device makers

$471in general payments, 2019–2025

Across 29 payments — averaging $16.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$112
  • UCB, Inc.$107
  • Teva Pharmaceuticals USA, Inc.$66
  • Otsuka America Pharmaceutical, Inc.$62
  • Jazz Pharmaceuticals Inc.$31
  • Indivior Inc.$29
  • plus $65 from 4 others

What the payments were for

  • Food & beverage$471100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$471 in reported general payments places this provider in the 50th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$778
Medicare patients
22
Services billed
80

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EpidiolexCannabidiol (Cbd)44$233,961
XcopriCenobamate27$42,519
NayzilamMidazolam23$30,398
VimpatLacosamide24$26,857
ZonisadeZonisamide13$20,829
BriviactBrivaracetam13$19,720
Lamotrigine ErLamotrigine64$17,411
AptiomEslicarbazepine Acetate12$15,566
Lacosamide111$13,299
Oxcarbazepine22$10,879
LinzessLinaclotide16$8,897
Clobazam24$6,837
JanuviaSitagliptin Phosphate12$6,807
Divalproex Sodium ErDivalproex Sodium43$5,955
Calcitonin-SalmonCalcitonin,salmon,synthetic66$5,344

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
UCB, Inc.Nayzilam, Vimpat, Briviact$107$76,97560 claims
Sunovion Pharmaceuticals Inc.Aptiom$112$15,56612 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,374 family providers in Kentucky.

Other family in Somerset

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →